The National Institute for Korean Medicine Development held an investment attraction briefing for promising companies leading the future of the Korean medicine industry at Post Tower, Seoul Central Post Office.


The event, held on October 21 as part of the 2026 Daegu-Gyeongbuk Korean Medicine Company Investment Capacity-Building Consulting and Investment Consultation Program, was organized to expand investment opportunities for promising local companies.

Investment Attraction Briefing for Promising Companies. [Photo provided by the National Institute for Korean Medicine Development]

Investment Attraction Briefing for Promising Companies. [Photo provided by the National Institute for Korean Medicine Development]

View original image

The institute supported 10 companies selected through an open call with on-site business assessments and tailored consulting starting in late August, helping them develop specific business models.


The event featured a first session with investment presentations, followed by a second session of one-on-one consultations.


The participating companies presented innovative business models, including food and cosmetics based on Korean medicine ingredients, AI-powered customized manufacturing systems, and smokeless moxibustion devices. They discussed specific funding plans and potential partnerships with investors.



The National Institute for Korean Medicine Development plans to continue providing active support to help the companies secure actual investments through ongoing follow-up management, including arranging follow-up meetings and conducting phased monitoring.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing